Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 165

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 2
Chunk 165
---
 to evaluate the performance of the business, because such measure, when viewed together with our financial results computed in accordance with GAAP, provides a more complete understanding of the factors and trends affecting our historical financial performance and projected future results. We believe this measure is useful because it excludes the effects of financing and investment activities as well as non-operating activities.

Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Net sales from discontinued operations$29.0 $43.1 $98.7 $170.8 EBITDA from discontinued operations$6.6 $(4.5)$8.0 $(26.8)

Net Sales Comparison of Three and Nine Months Ended September 30, 2025 and September 30, 2024:Change vs. prior yearIn millionsPrior year Net salesVolumePrice/MixCurrency effectCurrent year Net salesThree months ended September 30, 2025 vs. 2024$43.1 (10.7)(3.5)0.1 $29.0 Nine months ended September 30, 2025 vs. 2024$170.8 (67.8)(5.2)0.9 $98.7 

Three Months Ended September 30, 2025 vs. 2024

Net sales from discontinued operations. The decrease of $14.1 million in 2025 was driven by volume decline of $10.7 million (25 percent), unfavorable pricing and sales mix of $3.5 million (eight percent), partially offset by favorable foreign currency exchange of $0.1 million (zero percent).

EBITDA from discontinued operations. The increase of $11.1 million in 2025 was driven by lower manufacturing costs of $6.3 million and LIFO liquidation benefit of $5.7 million, and favorable foreign currency exchange and other charges of $1.6 million, which included a one time insurance settlement of $1.0 million in 2025. The increase was partially offset by volume decline of $1.8 million and unfavorable pricing and sales mix of $0.7 million.

Nine Months Ended September 30, 2025 vs. 2024

Net sales from discontinued operations. The decrease of $72.1 million in 2025 was driven by a volume decline of $67.8 million (40 percent), and unfavorable pricing and sales mix of $5.2 million